Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 278 000 KRW -1.07% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hanmi Pharm Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

14.2
Current
21
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
14.2
=
Enterprise Value
3.7T KRW
/
EBIT
262.4B KRW
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
13.8
2-Years Forward
EV/EBIT
13
3-Years Forward
EV/EBIT
11.4

See Also

Discover More